Biotechnology.report

Ichnos Sciences has entered into an exclusive worldwide licensing agreement for its OX40 antagonist monoclonal antibody portfolio with Astria Therapeutics, Inc., a biopharmaceutical company developing therapies for rare allergic and immunological diseases.

Read the full news on the link below:
https://bit.ly/48NbkHt

Ichnos Sciences Enters Licensing Agreement For Ox40 Antagonist Ichnos Sciences, a global clinical-stage biotechnology company developing innovative multispecific antibodies for oncology

MEDIA 7's The Biotechnology.Report cordially invites you to be a part of World Smart Bioprocessing: Pharma 4.0 Summit, set to take place in Berlin, Germany, from 27th - 29th September 2023.

Join the world technology leaders from Pharma, Biotech, and Pharma suppliers to share case studies and interactive breakouts towards commercial progress. This event is a unique opportunity to connect with global scientists, engineers, and executives working across the entire spectrum of biopharmaceutical development and production.

More details are available at: https://tinyurl.com/3xn49ywk

Featured Speakers: Bjørn Voldborg | Alice Harrison | M. Nicolas Cruz B. | Duygu Dikicioglu | Florian Schelter | Gerald Gellermann | David Ausländer | Chrysanthi Sitmalidou | Dan Bach Kristensen | Baerbel Grossmann | Peter Neubauer | Dr. Ulrich Rümenapp

Date: 27th - 29th September 2023
Physical | Cparity Event | Charles Williams

Register now: https://tinyurl.com/3xn49ywk

Smart Bioprocessing & Pharma 4.0 Summit Today’s Bioprocessing is the base of several emerging industries and technologies

Exacta BioScience and Ginkgo Bioworks, Inc. have announced a partnership to enhance one of Exacta's crop protection products, FitoRoot®, through a fermentation optimization and scale-up program.

Click the link below to read the full news:
https://tinyurl.com/5drj7tz8

Exacta Bioscience and Ginkgo Bioworks Announce Partnership Exacta Bioscience, a biotech company that harnesses the power of nature and its microorganisms for crop protection, and Ginkgo Bioworks

Watchmaker Genomics announces a multi-year agreement with Exact Sciences to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine borane sequencing (TAPS), for advanced applications including cancer screening and minimal residual disease (MRD) testing.

Click the link below to read the full news:
https://tinyurl.com/5668f7ws

Watchmaker Genomics Announces Co-Exclusive License to Disruptive Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact

Synthego Corporation, the pioneering force behind industrialized genome editing solutions, and bit.bio, the visionary cell coding company, have united to create a groundbreaking platform that's set to reshape the future of medicine.

Dive into the full news and get ahead of the curve:
https://tinyurl.com/34bercuu